Silorap D8 Tablets

Composition:

Silodosin 8mg and Dutasteride 0.5mg tablets

About Silorap D8 Tablets

Silorap-D8 is a dual-mechanism combination therapy for the effective management Benign Prostatic Hyperplasia (BPH) with moderate to severe LUTS.

  • Silodosin -a fast-acting, highly selective α1A-blocker, relaxes prostate and bladder neck muscles → Improves urinary flow & symptoms
  • Dutasteride -a dual 5α-reductase inhibitor, inhibits conversion of testosterone to DHT → Shrinks prostate and slows progression

Silorap D8 Tablets

*To be consumed as directed by physician.


Usage Instructions

This medicine is used the in the treatment of benign prostatic hyperplasia (prostate enlargement), a condition characterized by symptoms such as a weak urinary stream, difficulty urinating, loss of bladder control, etc.

Benefits and Use

  • Rapid symptom relief (Silodosin) + long-term disease control (Dutasteride).
  • Greater reduction in IPSS and Qmax vs monotherapy
  • Cardiovascular tolerability is high and reduces incidences of Orthostatic hypertension.